Zoetis Inc Earnings Cheat Sheet
Revenue: Decreased 0% to $1.09 billion from the year-earlier quarter.
Actual vs. Wall St. Expectations: reported adjusted EPS income of $0.36 per share. By that measure, the company beat the mean analyst estimate of $0.33. It beat the average revenue estimate of $1.08 billion.
Quoting Management: “At Zoetis, we are committed to delivering high-quality medicines and vaccines to the veterinarians and livestock producers we serve around the world, and building on our premier commercial, R&D and manufacturing capabilities to maintain our market leadership,” said Juan Ramón Alaix, chief executive officer of Zoetis. “As a newly formed standalone company, we are singularly focused on the animal health industry to improve our ability to serve those who raise and care for animals.”
Key Stats (on next page)…
Revenue decreased 0% from $0 in the previous quarter. EPS increased 227.27% from $0.11 in the previous quarter.
Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a loss of $0 to a profit $0.36. For the current year, the average estimate has moved up from a loss of $0 to a profit of $1.38 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)